Patents by Inventor Ibolya Horvath
Ibolya Horvath has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11111076Abstract: With respect to a transfer facility configured to optimize package transfers therethrough, a container housing packages may be delivered to a first floor of the transfer facility. The packages may be transported to consolidation stations based on destinations associated therewith. In some examples, the packages may be bound for a single destination and thus transported to a single consolidation station. In some examples, the packages may be bound for multiple destinations and thus transported to a second floor of the transfer facility for sortation. A destination and mode of transportation associated with the package may be determined at an induction station on the second floor, as well as a consolidation station associated therewith. A drive unit may insert the package into a chute for transit down a slide to the consolidation station, where it may be placed into another container for shipment to the destination via the mode of transportation.Type: GrantFiled: October 12, 2020Date of Patent: September 7, 2021Assignee: Amazon Technologies, Inc.Inventors: Stephen T. Campbell, Robert M Whitten, Shilpi Gupta, Ibolya Horvath, Oksana Mikhailovna Kharchenko, Justina Lakinger, Ryan Clarke
-
Patent number: 10800608Abstract: With respect to a transfer facility configured to optimize package transfers therethrough, a container housing packages may be delivered to a first floor of the transfer facility. The packages may be transported to consolidation stations based on destinations associated therewith. In some examples, the packages may be bound for a single destination and thus transported to a single consolidation station. In some examples, the packages may be bound for multiple destinations and thus transported to a second floor of the transfer facility for sortation. A destination and mode of transportation associated with the package may be determined at an induction station on the second floor, as well as a consolidation station associated therewith. A drive unit may insert the package into a chute for transit down a slide to the consolidation station, where it may be placed into another container for shipment to the destination via the mode of transportation.Type: GrantFiled: June 3, 2019Date of Patent: October 13, 2020Assignee: Amazon Technologies, Inc.Inventors: Stephen T. Campbell, Robert M Whitten, Shilpi Gupta, Ibolya Horvath, Oksana Mikhailovna Kharchenko, Justina Lakinger, Ryan Clarke
-
Patent number: 10660789Abstract: The invention provides 1,4-dihydropyridine derivatives of formula (I) wherein R1 is optionally substituted C6-24aryl group or 5 to 6 membered heteroaryl group comprising 1 to 3 nitrogen atoms or other heteroatoms like oxygen and sulphur, and combinations thereof; R2 and R3 are independently hydrogen or C1-6alkyl group; R4 and R5 are independently hydrogen, C1-6alkyl group optionally substituted with amino, mono- or di(C1-6alkyl)amino, or with 5 to 24 membered optionally fused heterocyclic ring attached by nitrogen and optionally comprising additional 1 to 3 N, O, S heteroatoms and optionally substituted with C1-6alkyl group or C1-6 alkoxy group; R6 is C1-6alkyl, C3-7cycloalkyl, C3-7cycloalkylC1-6alkyl or arylC1-6alkyl group; and stereoisomers including enantiomers, diastereomers, racemic mixtures, mixture of enantiomers and combination thereof, as well as polymorphs, pharmaceutically acceptable salts, solvates, esters and prodrugs thereof for use in the therapeutic or prophylactic treatment of a disorder mediType: GrantFiled: February 28, 2019Date of Patent: May 26, 2020Assignee: RICHTER GEDEON NYRT.Inventors: Ferenc Fülöp, László Vígh, Zsolt Török, Botond Penke, Ibolya Horváth, Gábor Balogh, Sándor Bernáth, Ákos Hunya
-
Publication number: 20190192336Abstract: The invention provides 1,4-dihydropyridine derivatives of formula (I) wherein R1 is optionally substituted C6-24aryl group or 5 to 6 membered heteroaryl group comprising 1 to 3 nitrogen atoms or other heteroatoms like oxygen and sulphur, and combinations thereof; R2 and R3 are independently hydrogen or C1-6alkyl group; R4 and R5 are independently hydrogen, C1-6alkyl group optionally substituted with amino, mono- or di(C1-6alkyl)amino, or with 5 to 24 membered optionally fused heterocyclic ring attached by nitrogen and optionally comprising additional 1 to 3 N, O, S heteroatoms and optionally substituted with C1-6alkyl group or C1-6 alkoxy group; R6 is C1-6alkyl, C3-7cycloalkyl, C3-7cycloalkylC1-6alkyl or arylC1-6alkyl group; and stereoisomers including enantiomers, diastereomers, racemic mixtures, mixture of enantiomers and combination thereof, as well as polymorphs, pharmaceutically acceptable salts, solvates, esters and prodrugs thereof for use in the therapeutic or prophylactic treatment of a disorder mediType: ApplicationFiled: February 28, 2019Publication date: June 27, 2019Inventors: Ferenc FÜLÖP, László VÍGH, Zsolt TÖRÖK, Botond PENKE, Ibolya HORVÁTH, Gábor BALOGH, Sándor BERNÁTH, Ákos HUNYA
-
Patent number: 10258498Abstract: The invention provides 1,4-dihydropyridine derivatives of formula (I) wherein R1 is optionally substituted C6-24aryl group or 5 to 6 membered heteroaryl group comprising 1 to 3 nitrogen atoms or other heteroatoms like oxygen and sulphur, and combinations thereof; R2 and R3 are independently hydrogen or C1-6alkyl group; R4 and R5 are independently hydrogen, C1-6alkyl group optionally substituted with amino, mono- or di(C1-6alkyl)amino, or with 5 to 24 membered optionally fused heterocyclic ring attached by nitrogen and optionally comprising additional 1 to 3 N, O, S heteroatoms and optionally substituted with C1-6alkyl group or C1-6 alkoxy group; R6 is C1-6alkyl, C3-7cycloalkyl, C3-7cycloalkylC1-6alkyl or arylC1-6alkyl group; and stereoisomers including enantiomers, diastereomers, racemic mixtures, mixture of enantiomers and combination thereof, as well as polymorphs, pharmaceutically acceptable salts, solvates, esters and prodrugs thereof for use in the therapeutic or prophylactic treatment of a disorder mediType: GrantFiled: November 22, 2012Date of Patent: April 16, 2019Assignee: Richter Gedeon NYRT.Inventors: Ferenc Fülöp, László Vigh, Zsolt Török, Botond Penke, Ibolya Horváth, Gábor Balogh, Sándor Bernáth, Ákos Hunya
-
Patent number: 9475639Abstract: An inventory system can receive a receipt receptacle from a shipping vehicle. The receipt receptacle can be moved to a case shuttle without separating or sorting inventory items in the receipt receptacle. A mobile drive unit can move the case shuttle to a receiving station, where the receipt receptacle can be removed and where the inventory items can be stowed in a pickable inventory holder. A mobile drive unit can move the pickable inventory holder to an order-compiling station, where inventory items can be picked from the inventory holder into order receptacles. A mobile drive unit can move an order shuttle carrying order receptacles with completed orders to a shipping station, where the completed order receptacles can be transferred to a shipping vehicle.Type: GrantFiled: November 24, 2014Date of Patent: October 25, 2016Assignee: Amazon Technologies, Inc.Inventors: Michael Cordell Mountz, Jonathan Harris Schechter, John Joseph Enright, Joseph W. Durham, Ibolya Horvath, Eryk Brian Nice, Michael Harrison Decker, Peter R. Wurman, Robert Raymond Ambrogi, Timothy Aaron Bragg
-
Publication number: 20160145044Abstract: An inventory system can receive a receipt receptacle from a shipping vehicle. The receipt receptacle can be moved to a case shuttle without separating or sorting inventory items in the receipt receptacle. A mobile drive unit can move the case shuttle to a receiving station, where the receipt receptacle can be removed and where the inventory items can be stowed in a pickable inventory holder. A mobile drive unit can move the pickable inventory holder to an order-compiling station, where inventory items can be picked from the inventory holder into order receptacles. A mobile drive unit can move an order shuttle carrying order receptacles with completed orders to a shipping station, where the completed order receptacles can be transferred to a shipping vehicle.Type: ApplicationFiled: November 24, 2014Publication date: May 26, 2016Inventors: Michael Cordell Mountz, Jonathan Harris Schechter, John Joseph Enright, Joseph W. Durham, Ibolya Horvath, Eryk Brian Nice, Michael Harrison Decker, Peter R. Wurman, Robert Raymond Ambrogi, Timothy Aaron Bragg
-
Publication number: 20140315893Abstract: The invention provides 1,4-dihydropyridine derivatives of formula (I) wherein R1 is optionally substituted C6-24aryl group or 5 to 6 membered heteroaryl group comprising 1 to 3 nitrogen atoms or other heteroatoms like oxygen and sulphur, and combinations thereof; R2 and R3 are independently hydrogen or C1-6alkyl group; R4 and R5 are independently hydrogen, C1-6alkyl group optionally substituted with amino, mono- or di(C1-6alkyl)amino, or with 5 to 24 membered optionally fused heterocyclic ring attached by nitrogen and optionally comprising additional 1 to 3 N, O, S heteroatoms and optionally substituted with C1-6alkyl group or C1-6 alkoxy group; R6 is C1-6alkyl, C3-7cycloalkyl, C3-7cycloalkylC1-6alkyl or arylC1-6alkyl group; and stereoisomers including enantiomers, diastereomers, racemic mixtures, mixture of enantiomers and combination thereof, as well as polymorphs, pharmaceutically acceptable salts, solvates, esters and prodrugs thereof for use in the therapeutic or prophylactic treatment of a disorder mediType: ApplicationFiled: November 22, 2012Publication date: October 23, 2014Inventors: Ferenc Fülöp, László Vígh, Zsolt Török, Botond Penke, Ibolya Horváth, Gábor Balogh, Sándor Bernáth, Ákos Hunya
-
Publication number: 20100267711Abstract: A method of increasing expression of a molecular chaperon by a cell and/or enhancing the activity of a molecular chaperon in cells is provided. The method comprises treating a cell that is exposed to a physiological stress which induces expression of a molecular chaperon by the cell with an effective amount of a certain hydroxylamine derivative to increase the stress. Alternatively, an hydroxylamine derivative can be administrated to a cell before it is exposed to a physiological stress which induces expression of a molecular chaperon by the cell. Preferably, the cell to which an hydroxylamine derivative is administered is an eukaryotic cell. The hydroxylamine derivative corresponds to the formulae (I) or (II). The invention also provides novel hydroxylamine derivatives falling within the scope of the formulae (I) and (II) as well as pharmaceutical and/or cosmetical compositions comprising the said compounds.Type: ApplicationFiled: June 25, 2010Publication date: October 21, 2010Applicant: CytRx CorporationInventors: László Vígh, Péter Literáti Nagy, Jenó Szilbereky, László Ürögdi, Andrea Jednákovits, László Jaszlits, Katalin Bíró, Ede Màrvànyos, Mihály Barabás, Erzsébet Hegedüs, László Korányi, Mária Kürthy, Gábor Balogh, Ibolya Horváth, Zsolt Török, Éva Udvardy, György Dormán, Dénes Medzihradszky, Bea Mézes, Eszter Kovács, Ernó Duda, Beatrix Farkas, Attila Glatz
-
Patent number: 7745465Abstract: A method of increasing expression of a molecular chaperon by a cell and/or enhancing the activity of a molecular chaperon in cells is provided. The method comprises treating a cell that is exposed to a physiological stress which induces expression of a molecular chaperon by the cell with an effective amount of a certain hydroxylamine derivative to increase the stress. Alternatively, an hydroxylamine derivative can be administrated to a cell before it is exposed to a physiological stress which induces expression of a molecular chaperon by the cell. Preferably, the cell to which an hydroxylamine derivative is administered is an eukaryotic cell. The hydroxylamine derivative corresponds to the formulae (I) or (II). The invention also provides novel hydroxylamine derivatives falling within the scope of the formulae (I) and (II) as well as pharmaceutical and/or cosmetical compositions comprising the said compounds.Type: GrantFiled: July 10, 2003Date of Patent: June 29, 2010Assignee: CytRx CorporationInventors: László Vígh, Péter Literáti Nagy, Jenö Szilbereky, László Ürögdi, Andrea Jednákovits, László Jaszlits, Katalin Bíró, Ede Márványos, Mihály Barabás, Erzsébet Hegedüs, László Korányi, Mária Kürthy, Gábor Balogh, Ibolya Horváth, Zsolt Török, Éva Udvardy, György Dormán, Dénes Medzihradszky, Bea Mézes, Eszter Kovács, Ernö Duda, Beatrix Farkas, Attila Glatz
-
Patent number: 7148239Abstract: A method of increasing expression of a molecular chaperon by a cell and/or enhancing the activity of a molecular chaperon in cells is provided. The method comprises treating a cell that is exposed to a physiological stress which induces expression of a molecular chaperon by the cell with an effective amount of a certain hydroxylamine derivative to increase the stress. Alternatively, an hydroxylamine derivative can be administrated to a cell before it is exposed to a physiological stress which induces expression of a molecular chaperon by the cell. Preferably, the cell to which an hydroxylamine derivative is administered is an eukaryotic cell. The hydroxylamine derivative corresponds to the formulae (I) or (II). The invention also provides novel hydroxylamine derivatives falling within the scope of the formulae (I) and (II) as well as pharmaceutical and/or cosmetical compositions comprising the said compounds.Type: GrantFiled: July 10, 2003Date of Patent: December 12, 2006Assignee: CytRx CorporationInventors: László Vígh, Péter Literáti Nagy, Jenó Szilbereky, László Ürögdi, Andrea Jednákovits, László Jaszlits, Katalin Bíró, Ede Márványos, Mihály Barabás, Erzsébet Hegedüs, László Korányi, Mária Kürthy, Gábor Balogh, Ibolya Horváth, Zsolt Török, Éva Udvardy, György Dormán, Dénes Medzihradszky, Bea Mézes, Eszter Kovács, Ernó Duda, Beatrix Farkas, Attila Glatz
-
Publication number: 20040067940Abstract: A method of increasing expression of a molecular chaperon by a cell and/or enhancing the activity of a molecular chaperon in cells is provided. The method comprises treating a cell that is exposed to a physiological stress which induces expression of a molecular chaperon by the cell with an effective amount of a certain hydroxylamine derivative to increase the stress. Alternatively, an hydroxylamine derivative can be administrated to a cell before it is exposed to a physiological stress which induces expression of a molecular chaperon by the cell. Preferably, the cell to which an hydroxylamine derivative is administered is an eukaryotic cell. The hydroxylamine derivative corresponds to the formulae (I) or (II). The invention also provides novel hydroxylamine derivatives falling within the scope of the formulae (I) and (II) as well as pharmaceutical and/or cosmetical compositions comprising the said compounds.Type: ApplicationFiled: July 10, 2003Publication date: April 8, 2004Applicant: Biorex Research & Development Co.Inventors: Laszlo Vigh, Peter Literati Nagy, Jeno Szilbereky, Laszlo Urogdi, Andrea Jednakovits, Laszlo Jaszlits, Katalin Biro, Ede Marvanyos, Mihaly Barabas, Erzsebet Hegedus, Laszlo Koranyi, Maria Kurthy, Gabor Balogh, Ibolya Horvath, Zsolt Torok, Eva Udvardy, Gyorgy Dorman, Denes Medzihradszky, Bea Mezes, Eszter Kovacs, Erno Duda, Beatrix Farkas, Attila Glatz
-
Publication number: 20040019103Abstract: A method of increasing expression of a molecular chaperon by a cell and/or enhancing the activity of a molecular chaperon in cells is provided. The method comprises treating a cell that is exposed to a physiological stress which induces expression of a molecular chaperon by the cell with an effective amount of a certain hydroxylamine derivative to increase the stress. Alternatively, an hydroxylamine derivative can be administrated to a cell before it is exposed to a physiological stress which induces expression of a molecular chaperon by the cell. Preferably, the cell to which an hydroxylamine derivative is administered is an eukaryotic cell. The hydroxylamine derivative corresponds to the formulae (I) or (II).Type: ApplicationFiled: July 10, 2003Publication date: January 29, 2004Applicant: Biorex Research & Development Co.Inventors: Laszlo Vigh, Peter Literati Nagy, Jeno Szilbereky, Laszlo Urogdi, Andrea Jednakovits, Laszlo Jaszlits, Katalin Biro, Ede Marvanyos, Mihaly Barabas, Erzsebet Hegedus, Laszlo Koranyi, Maria Kurthy, Gabor Balogh, Ibolya Horvath, Zsolt Torok, Eva Udvardy, Gyorgy Dorman, Denes Medzihradszky, Bea Mezes, Eszter Kovacs, Erno Duda, Beatrix Farkas, Attila Glatz
-
Patent number: 6653326Abstract: A method of increasing expression of a molecular chaperon by a cell and/or enhancing the activity of a molecular chaperon in cells is provided. The method comprises treating a cell that is exposed to a physiological stress which induces expression of a molecular chaperon by the cell with an effective amount of a certain hydroxylamine derivative to increase the stress. Alternatively; an hydroxylamine derivative can be administrated to a cell before it is exposed to a physiological stress which induces expression of a molecular chaperon by the cell. Preferably, the cell to which an hydroxylamine derivative is administered is an eukaryotic cell. The hydroxylamine derivative corresponds to the formulae (I) or (II). The invention also provides novel hydroxyl amine derivatives falling within the scope of the formulae (I) and (II) as well as pharmaceutical and/or cosmetical compositions comprising the said compounds.Type: GrantFiled: December 7, 1999Date of Patent: November 25, 2003Assignee: Biorex Research & Development Co.Inventors: László Vígh, Péter Literáti Nagy, Jenó Szilbereky, László Ürögdi, Andrea Jednákovits, László Jaszlits, Katalin Bíró, Ede Màrvànyos, Mihály Barabás, Erzsébet Hegedüs, László Korányi, Mária Kürthy, Gábor Balogh, Ibolya Horváth, Zsolt Török, Éva Udvardy, György Dormán, Dénes Medzihradszky, Bea Mézes, Eszter Kovács, Ernö Duda, Beatrix Farkas, Attila Glatz
-
Patent number: 4554252Abstract: Disclosed is a process for improving the efficiency of in vitro propagation and tissue cultivating by tissue culture of cultivated of plants which comprises treating the plants during micropropagation and/or subsequent planting with an aqueous solution of one or a mixture of substituted amides or one or a mixture of substituted diamides.Type: GrantFiled: December 13, 1982Date of Patent: November 19, 1985Assignee: Eszakmagyarorszagi VegyimuvekInventors: Tibor Farkas, Laszlo Vigh, Ibolya Horvath, Aniko Nagy nee Vanicsek, Ferenc Foglein, Annamaria Meszaros, Istvan Toth
-
Patent number: 4493727Abstract: The invention relates to a plant growth regulating composition which contains as active agent a compound of general formula (I) ##STR1## wherein R.sub.1 and R.sub.2 can be identical or different and can stand for hydrogen, a C.sub.1-4 straight or branched alkyl group, cyclohexyl, phenyl, chlorophenyl, alkylphenyl, benzyl or alkylbenzyl group, or R.sub.1 and R.sub.2 can together with the N atoms form a heterocyclic ring.The growing of plants can be stimulated and the green weight can be increased to a significant degree by the treatment carried out with the composition of the invention.Type: GrantFiled: November 3, 1982Date of Patent: January 15, 1985Assignee: Eszakmagyarorszagi VegyimuvekInventors: Istvan Toth, Jozsef Nagy, Zsolt Dombay, Erzsebet Grega nee Toth, Ibolya Horvath, Laszlo Vigh, Tibor Farkas
-
Patent number: 4488901Abstract: The invention relates to new compositions for increasing the cold resistance of cultivated plants. These compositions contain as active ingredient at least one compound of the general formula (I), ##STR1## wherein n is an integer of 2 to 5 and R.sub.1, R.sub.2 and R.sub.3 each stand for hydrogen or C.sub.1-5 alkyl, or an acid addition salt thereof in an amount of 0.01 to 70% by weight, together with a conventional diluent and/or additive.The plants treated with the compositions according to the invention are more resistant to cold and frost.Type: GrantFiled: December 17, 1981Date of Patent: December 18, 1984Assignee: Eszakmagyarorszagi VegyimuvekInventors: Tibor Farkas, Ibolya Horvath, Laszlo I. Horvath, Laszlo Vigh, Zsolt Dombay, Jozsef Nagy, Emilia Nagy nee Gera, Csaba Pavliscsak, Gyula Tarpai